Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

US FDA-approved therapeutic antibodies with high-concentration formulation: summaries and perspectives
Shawn Shouye Wang, Yifei Yan, K. Lee Ho
Antibody Therapeutics (2021) Vol. 4, Iss. 4, pp. 262-272
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

A systematic review of commercial high concentration antibody drug products approved in the US: formulation composition, dosage form design and primary packaging considerations
Indrajit Ghosh, Hiten J. Gutka, Mary E. Krause, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 43
Blueprint for antibody biologics developability
Carl Mieczkowski, Xuejin Zhang, Dana Lee, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 30
Recent Progress in Development and Application of DNA, Protein, Peptide, Glycan, Antibody, and Aptamer Microarrays
G. M. Aparna, Kishore K. R. Tetala
Biomolecules (2023) Vol. 13, Iss. 4, pp. 602-602
Open Access | Times Cited: 28
Effects of arginine in therapeutic protein formulations: a decade review and perspectives
Steven Ren
Antibody Therapeutics (2023) Vol. 6, Iss. 4, pp. 265-276
Open Access | Times Cited: 23
Molecular and functional insight into anti-EGFR nanobody: Theranostic implications for malignancies
Rajan K. Tripathy, Abhay H. Pande
Life Sciences (2024) Vol. 345, pp. 122593-122593
Closed Access | Times Cited: 9
Alternative Excipients for Protein Stabilization in Protein Therapeutics: Overcoming the Limitations of Polysorbates
A. Ruiz, Maryam A. Shetab Boushehri, Tamara Phan, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2575-2575
Open Access | Times Cited: 37
The Evolution of Commercial Antibody Formulations
Carl Mieczkowski
Journal of Pharmaceutical Sciences (2023) Vol. 112, Iss. 7, pp. 1801-1810
Open Access | Times Cited: 17
Molecular Farming of Pembrolizumab and Nivolumab
M. Stark, A.M. Joubert, Michelle Helen Visagie
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10045-10045
Open Access | Times Cited: 17
Histidine as a versatile excipient in the protein-based biopharmaceutical formulations
Jia-Yi Lv, Rahul G Ingle, Hao Wu, et al.
International Journal of Pharmaceutics (2024) Vol. 662, pp. 124472-124472
Closed Access | Times Cited: 7
A Comprehensive Review of Monoclonal Antibodies in Modern Medicine: Tracing the Evolution of a Revolutionary Therapeutic Approach
M. Kothari, Anil Wanjari, Sourya Acharya, et al.
Cureus (2024)
Open Access | Times Cited: 6
Monoclonal antibody and protein therapeutic formulations for subcutaneous delivery: high-concentration, low-volume vs. low-concentration, high-volume
Mukesh Desai, Amit Kundu, Michiel Hageman, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Coarse-Grained Molecular Dynamics Simulation of Heterogeneous Polysorbate 80 Surfactants and their Interactions with Small Molecules and Proteins
Hao Lou, Yaqi Wu, Krzysztof Kuczera, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 10, pp. 5041-5052
Closed Access | Times Cited: 5
Advancing humanized monoclonal antibody for counteracting fentanyl toxicity towards clinical development
Dustin Hicks, Carly Baehr, Pedro Silva-Ortiz, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 6
Open Access | Times Cited: 21
The efficacy of the entire-vial dosing of emicizumab: Real-world evidence on plasma concentrations, bleeds, and drug waste
Anouk A. M. T. Donners, Konrad van der Zwet, Carin M. A. Rademaker, et al.
Research and Practice in Thrombosis and Haemostasis (2023) Vol. 7, Iss. 2, pp. 100074-100074
Open Access | Times Cited: 12
Subclass Effects on Self-Association and Viscosity of Monoclonal Antibodies at High Concentrations
Amjad Chowdhury, Neha Manohar, Marta A. Witek, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 6, pp. 2991-3008
Closed Access | Times Cited: 12
Biophysical Determinants for the Viscosity of Concentrated Monoclonal Antibody Solutions
Ilaria Mosca, Kévin Pounot, Christian Beck, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 9, pp. 4698-4713
Closed Access | Times Cited: 12
Crystalline Antibody‐Laden Alginate Particles: A Platform for Enabling High Concentration Subcutaneous Delivery of Antibodies
Amir Erfani, Jeremy M. Schieferstein, Paul Reichert, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 15
Open Access | Times Cited: 11
Near UV Photodegradation Mechanisms of Amino Acid Excipients: Formation of the Carbon Dioxide Radical Anion from Aspartate and Fe(III)
Yilue Zhang, Yaqi Wu, Christian Schöneich
Molecular Pharmaceutics (2024) Vol. 21, Iss. 3, pp. 1233-1245
Closed Access | Times Cited: 4
Correlating Surface Activity with Interface-Induced Aggregation in a High-Concentration mAb Solution
Estephanie Laura Nottar Escobar, Valerie P. Griffin, Prajnaparamita Dhar
Molecular Pharmaceutics (2024) Vol. 21, Iss. 3, pp. 1490-1500
Closed Access | Times Cited: 4
Monoclonal antibodies: From magic bullet to precision weapon
Hassan Aboul-Ella, Asmaa Gohar, Aya Ahmed Ali, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 4
The role of Histidine buffer in the iron-catalyzed formation of oxidizing species in pharmaceutical formulations: mechanistic studies
Yilue Zhang, Yaqi Wu, Christian Schöneich
Journal of Pharmaceutical Sciences (2025)
Closed Access
A novel antibody against GPIbα inhibits platelet function and thrombosis without increasing bleeding
Lili Zhao, Jiahao Du, Yuxin Jin, et al.
International Journal of Biological Macromolecules (2025), pp. 140739-140739
Closed Access
An industry perspective on hyaluronidase co-formulated biopharmaceutics
Jeremy Guo, Jingwen Weng, Fangyuan Zhou, et al.
Journal of Controlled Release (2025)
Closed Access
Exploring the Application of Single-step Drying in Lyophilization of High Protein Concentration Formulations
Qi Zeng, Zhaowei Jin, Jeremy Guo
Pharmaceutical Development and Technology (2025), pp. 1-13
Closed Access
Vaginally-delivered fast-dissolving antibody tablets (FDAT) for on-demand non-hormonal contraception and multi-purpose protection
Keiichiro Kushiro, Scott Hammers, Yong Zhu, et al.
Journal of Controlled Release (2025), pp. 113662-113662
Closed Access
Page 1 - Next Page

Scroll to top